Skip to main content

Parkinsonian Tremor News (Page 3)

Retired Rugby Players Face Risks for Dementia, CTE

THURSDAY, July 18, 2024 – Alix Popham played in two rugby World Cups and won a Six Nations Grand Slam before retiring in 2011 as a professional in the rough-and-tumble game. By 2020, he had already...

Could Contact Sports Raise Risks for a Parkinson's-like Disorder?

WEDNESDAY, July 17, 2024 – Autopsies of deceased boxers and pro football players have long confirmed that repeat head injuries can lead to a devastating brain condition known as chronic traumatic...

Structure, Function of Brain Connectome Tied to Gray Matter Atrophy in Parkinson Disease

MONDAY, July 8, 2024 – For patients with mild Parkinson disease (PD), the structural and functional architecture of the brain connectome is associated with progression of gray matter (GM) atrophy,...

FDA Approves Ongentys (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes

SAN DIEGO – April 27, 2020 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Ongentys (opicapone) 25 mg and 50...

FDA Approves Xadago (safinamide) as an Add-On Treatment for Patients with Parkinson’s Disease

March 21, 2017 – The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking l...

FDA Medwatch Alert: Benztropine Mesylate Injection (Nexus Pharmaceuticals): Recall - Visible Particulate Matter

ISSUE: Nexus Pharmaceuticals Inc. is recalling two lots of Benztropine Mesylate Injection, USP, 2 mg/2mL (1mg/mL) in 2 mL single dose vials due to the presence of visible particulate matter in the...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Parkinson's Disease